Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael R Beard

Showing results (11-20 of 79) with videos related to

Pageof 8
Sort By:
Antiviral Therapy|June 25, 2013
Bioinformatics methods for the analysis of hepatitis virusesFrancesco Moriconi, Michael R Beard, Lilly Kw Yuen
Hepatology (Baltimore, Md.)|September 30, 2011
Border patrol intensifies for hepatitis C virus entryErin M McCartney, Nicholas S Eyre, Michael R Beard
Antiviral Therapy|September 13, 2006
Genomics of hepatitis B and C infections: diagnostic and therapeutic applications of microarray profilingMark D Berzsenyi, Stuart K Roberts, Michael R Beard
Current Opinion in Virology|March 24, 2012
Resistance to anti-HCV protease inhibitorsAlexander J Thompson, Stephen A Locarnini, Michael R Beard
Plos Pathogens|October 16, 2010
The SR-BI partner PDZK1 facilitates hepatitis C virus entryNicholas S Eyre, Heidi E Drummer, Michael R Beard
Hepatology (Baltimore, Md.)|April 30, 2009
Closing the gap: the tight junction protein occludin and hepatitis C virus entryNicholas S Eyre, Thomas F Baumert, Michael R Beard
Vaccines|September 17, 2020
The Molecular Interactions of ZIKV and DENV with the Type-I IFN ResponseRosa C Coldbeck-Shackley, Nicholas S Eyre, Michael R Beard
Viruses|May 27, 2023
Identification of Key Residues in Dengue Virus NS1 Protein That Are Essential for Its SecretionBrandon E K Tan, Michael R Beard, Nicholas S Eyre
Hepatology (Baltimore, Md.)|May 1, 2002
Cellular response to conditional expression of hepatitis C virus core protein in Huh7 cultured human hepatoma cellsKui Li, Tarl Prow, Stanley M Lemon, et al.
Viruses|November 27, 2021
CRISPR Tackles Emerging Viral PathogensEmily N Kirby, Byron Shue, Paul Q Thomas, et al.
Pageof 8

Showing results (11-20 of 79) with videos related to

Sort By:
Pageof 8
Antiviral Therapy|June 25, 2013
Bioinformatics methods for the analysis of hepatitis virusesFrancesco Moriconi, Michael R Beard, Lilly Kw Yuen
Hepatology (Baltimore, Md.)|September 30, 2011
Border patrol intensifies for hepatitis C virus entryErin M McCartney, Nicholas S Eyre, Michael R Beard
Antiviral Therapy|September 13, 2006
Genomics of hepatitis B and C infections: diagnostic and therapeutic applications of microarray profilingMark D Berzsenyi, Stuart K Roberts, Michael R Beard
Current Opinion in Virology|March 24, 2012
Resistance to anti-HCV protease inhibitorsAlexander J Thompson, Stephen A Locarnini, Michael R Beard
Plos Pathogens|October 16, 2010
The SR-BI partner PDZK1 facilitates hepatitis C virus entryNicholas S Eyre, Heidi E Drummer, Michael R Beard
Hepatology (Baltimore, Md.)|April 30, 2009
Closing the gap: the tight junction protein occludin and hepatitis C virus entryNicholas S Eyre, Thomas F Baumert, Michael R Beard
Vaccines|September 17, 2020
The Molecular Interactions of ZIKV and DENV with the Type-I IFN ResponseRosa C Coldbeck-Shackley, Nicholas S Eyre, Michael R Beard
Viruses|May 27, 2023
Identification of Key Residues in Dengue Virus NS1 Protein That Are Essential for Its SecretionBrandon E K Tan, Michael R Beard, Nicholas S Eyre
Hepatology (Baltimore, Md.)|May 1, 2002
Cellular response to conditional expression of hepatitis C virus core protein in Huh7 cultured human hepatoma cellsKui Li, Tarl Prow, Stanley M Lemon, et al.
Viruses|November 27, 2021
CRISPR Tackles Emerging Viral PathogensEmily N Kirby, Byron Shue, Paul Q Thomas, et al.
Pageof 8